8/6/2019 EndoHPB Brochure Final
1/3
For the Palliation of Biliaryand Pancreatic Tumours
HabibTMEndoHPB
Endoscopy
8/6/2019 EndoHPB Brochure Final
2/3
With the ERCP approach a guidewire
is inserted in the CBD showing
complete biliary obstruction.
EndoHPB inserted via the ERCP
approach over the guidewire.
Following removal of the EndoHPB
catheter contrast is seen in the lower
end of the CBD.
Metal stent insertion following RF
ablation of an inoperable tumour in
the head of pancreas
The HabibTM EndoHPB
The HabibTM EndoHPB was cleared by
FDA 510 (k) to be used to assist in the
coagulation of tissue during Endoscopic
surgical procedures in the Gastro-intestinal
Tract.
This novel endoscopic bipolar radiofrequency
(RF) probe has been used for the
palliation of malignant biliary obstructions
from cholangiocarcinoma or pancreatic
adenocarcinoma.
The RF catheter has been used by
endoscopists for tumours in the bile duct
and head of pancreas for partial destruction
of the tumour prior to stent insertion and for
clearance of obstructed metal stents.
The HabibTM EndoHPB is an 8Fr (2.6mm)
catheter which has a useable length of 180cm
and two stainless steel ring electrodes at the
distal tip. It is compatible with endoscopes
that have a working channel 3.2mm or
greater. The catheter is introduced over a
0.035 guidewire into the common bile duct
(CBD) via the Ampulla of Vater. The catheter
is manipulated into the CBD where it is used
to heat and ablate tissue. The electrodes are
designed to operate at an efcient energy
level and are activated at 10 Watts for only 90
seconds before the stent is inserted.
A recent clinical trial reported in
Gastrointestinal Endoscopy Journal
of 22 patients (16 pancreatic, 6
cholangiocarcinoma) who were treated with
the EndoHPB catheter between January
2009 and April 2010. Deployment of the
catheter was successful in 21 patients. Self
Expanding Metal Stent (SEMS) placement
was achieved in all cases of successful
RFA catheter deployment. One patient
failed to demonstrate successful biliary
decompression after SEMS placement
and died within 90 days. All other patients
maintained stent patency at 30 days (Steel et
al GIE 2011;73:149-153).
The HabibTM EndoHPB can be used with
the following radiofrequency generators:
Radionics Cosman Coagulator CC-1, the
RITA Medical Systems 1500, the RITA
Medical Systems 1500X, the Conmed 5000,
the ERBE VIO 200D and the ERBE VIO
300D.
Please contact us at [email protected] or
visit www.emcision.com for more information
ENDOSCOPIC INSERTION ANDACTIVATION OF THE HABIBTM
ENDOHPB
8/6/2019 EndoHPB Brochure Final
3/3
IMPORTANT
Prior to use, refer to the Instructions for Use supplied with the
device for indications, contraindications, adverse effects,
suggested procedure, warnings, and precautions.
A 90cm length catheter specically for percutaneous
use is available to order (ordering information HabibTM
Percutaneous EndoHPB - Product number 6700).
PUBLICATION
Steel AW., et al. Endoscopically applied
radiofrequency ablation appears to be safe in
the treatment of malignant biliary obstruction.
Gastrointestinal Endoscopy 2011;73(1):149-
153.
HabibTM Endoblate
Ablation of tumours in hollow
organs
HabibTM VesCoag
For precise vascular occlusion
HabibTM Hexablate
Ablation of inoperable solid
tumours
Please contact us at [email protected] or
visit www.emcision.com for more information
OTHER EMCISIONPRODUCTS
6800 8Fr (2.6mm),
UseableLength 180cm
Cleared
Class II
Cleared
Class IIb
3 years Endoscope
3.2mm channel0.035 guidewire
HabibTM
EndoHPB
P/N Specications FDA Status
(class)
CE Status
(class)
Shelf life Required
accessories
EMD01 Rev 5
Top Related